Immunization News and Research

RSS

Study explores humoral and cellular immunity conferred by second and third COVID-19 BNT162b2 vaccination in elderly

Researchers recently assessed SARS-CoV-2-specific humoral and cellular immune responses induced by the second and third doses of the BNT162b2 COVID-19 messenger ribonucleic acid-based vaccine in the elderly.

17 Feb 2022

Memory B cell repertoire in a longitudinal cohort of individuals receiving 3 COVID-19 mRNA vaccine doses

Researchers examined the memory B cell repertoire of individuals immunized with three doses of mRNA-based COVID-19 vaccine.

17 Feb 2022

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Study looks at COVID-19 vaccine hesitancy in France and Italy

A recent study posted to Research Square* preprint server, and under consideration at the journal Scientific Reports, aimed to learn more about how and to what extent vaccine hesitancy can alter over time at the individual level by considering parameters such as dynamic preferences, news reporting, and gender influence.

16 Feb 2022

Characterization of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military

Researchers discuss the genomic and virological characterization of SARS-CoV-2 variants among unvaccinated and vaccinated U.S military personnel.

16 Feb 2022

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Researchers compare the incidence rate of reinfection in convalescent and unvaccinated people to that in recovered and single-dose vaccinated people.

16 Feb 2022

Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability

A new study explored the high immunogenicity and stability of lyophilized mRNA-LNP vaccines in relation to SARS-CoV-2.

16 Feb 2022

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

A new study evaluated the pregnancy outcomes of pregnant women in the third trimester who were infected by SARS-CoV-2 for the detection of the virus in the placenta and different samples of the newborn as well as detection of antibodies in the cord blood.

16 Feb 2022

Features of platelet-immune crosstalk in healthy recipients of two doses of mRNA-based SARS-CoV-2 vaccine BNT162b2

Researchers investigated the role of platelets in the adverse immune response against a COVID-19 vaccine.

16 Feb 2022

Study shows mRNA COVID-19 vaccination in pregnancy can prevent hospitalization among infants

A report published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) shows how primary two-dose vaccination series against coronavirus disease 2019 (COVID-19) during pregnancy is linked to a reduced risk of COVID-19–associated hospitalization among infants six months of age or younger.

16 Feb 2022

Real-world data on efficacy and safety of COVID vaccines in Canada

In a recent study posted to the medRxiv* preprint server, researchers evaluated the efficacy and safety of the coronavirus disease 2019 (COVID-19) vaccines in young and elderly cohorts from Canada.

14 Feb 2022

Study finds Pfizer-BioNTech COVID vaccine doesn't increase pregnancy risk

A new JAMA Network study describes the effects of maternal COVID-19 vaccination on pregnancy outcomes and infant health.

14 Feb 2022

Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants

A recent study demonstrated that intranasal (i.n.) delivery of COVID-19 vaccine in murine models elicits greater immune responses against the wildtype SARS-CoV-2 and its variants.

14 Feb 2022

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

In a study posted to the bioRxiv* preprint server, a team of researchers from the United States evaluated the protective effect of the preclinical version of the current Moderna Omicron-targeted mRNA-1273.529 vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron infection in mice.

14 Feb 2022

90 minutes of exercise after vaccination may provide an extra immune boost

Researchers at Iowa State University found 90 minutes of mild- to moderate-intensity exercise directly after a flu or COVID-19 vaccine may provide an extra immune boost.

12 Feb 2022

Rapid generation and evaluation of an mRNA vaccine candidate specific to Omicron

A recent study demonstrated the development of a potential SARS-CoV-2 Omicron variant-specific mRNA vaccine candidate.

10 Feb 2022

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo (DRC) that are experiencing outbreaks of the disease.

10 Feb 2022

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

The FDA will consider authorizing two doses of a COVID-19 vaccine for kids under 5 on an emergency basis, with the possibility for a third.

9 Feb 2022

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Researchers have conducted a prospective, longitudinal cohort study to analyze COVID-19 immunity in patients with cancer.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Immunization News and Research

Study explores humoral and cellular immunity conferred by second and third COVID-19 BNT162b2 vaccination in elderly

Memory B cell repertoire in a longitudinal cohort of individuals receiving 3 COVID-19 mRNA vaccine doses

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Study looks at COVID-19 vaccine hesitancy in France and Italy

Characterization of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

Features of platelet-immune crosstalk in healthy recipients of two doses of mRNA-based SARS-CoV-2 vaccine BNT162b2

Study shows mRNA COVID-19 vaccination in pregnancy can prevent hospitalization among infants

Real-world data on efficacy and safety of COVID vaccines in Canada

Study finds Pfizer-BioNTech COVID vaccine doesn't increase pregnancy risk

Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

90 minutes of exercise after vaccination may provide an extra immune boost

Rapid generation and evaluation of an mRNA vaccine candidate specific to Omicron

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News